TYRA logo

Tyra Biosciences, Inc. (TYRA)

Profile

Full Name

Tyra Biosciences, Inc.

Ticker

NASDAQ: TYRA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 15, 2021

Indexes

Not included

Website

https://tyra.bio

Employees

60

Key Details

Price

$12.52(+0.40%)

Market cap

$667.28M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$1.51(+6.79% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $12.52
    TYRA price is $12.52

    30-Day Relative Volume

    0.89
    TYRA 30-day relative volume is 0.89

    Price Performance

    Price Most recent change

    +0.4%
    TYRA price was up +0.4% on Sep 12, 2025

    Price YTD change

    -9.93%
    TYRA price is down -9.93% since January 1st

    Price 1-year change

    -41.05%
    TYRA price is down -41.05% year-on-year

    Price 3-year change

    +38.96%
    TYRA price is up +38.96% over the past 3 years

    Price Range

    Price All-time high

    $31.36
    TYRA price is currently -60.08% below its historical high of $31.36

    Price 3-year low

    $5.50
    TYRA price is currently +127.51% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $667.28M
    TYRA market capitalization is $667.28 million

    Market cap 3-year change

    +76.44%
    TYRA market capitalization is up +76.44% over the past 3 years

    Market cap All-time high

    $1.51B
    TYRA market capitalization is currently -55.89% below its historical high of $1.51 billion

    Market cap sector rank

    67.2%
    TYRA market capitalization is higher than 67.2% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.93%
    TYRA shares outstanding is up +0.93% year-on-year

    Shares Outstanding 3-Year Change

    +26.98%
    TYRA shares outstanding is up +26.98% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.11
    TYRA beta is 1.11

    200-day SMA

    $11.67
    TYRA price is currently +7.24% above its 200-day simple moving average

    50-day SMA

    $11.13
    TYRA price is currently +12.45% above its 50-day simple moving average

    RSI

    59.02
    TYRA 14-day relative strength index is 59.02

    Volume

    0.89
    TYRA 30-day relative volume is 0.89

    ATR

    $0.69
    TYRA average true range is $0.69

    10-day Historical Volatility

    46.05%
    TYRA 10-day historical volatility is 46.05%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    TYRA annual revenue is $0.00

    Revenue Analysts estimate

    -
    TYRA annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    TYRA annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    TYRA annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$1.51
    TYRA annual earnings per share is -$1.51

    EPS Analysts estimate

    -$2.01
    TYRA annual earnings per share is currently -24.86% lower than the consensus analysts' forecast

    EPS 1-year change

    +6.79%
    TYRA annual earnings per share is up +6.79% year-on-year

    EPS Sector rank

    42.69%
    TYRA annual earnings per share is higher than 42.69% of companies in Healthcare sector

    Profit

    Gross profit

    -$519.00K
    TYRA annual gross profit is -$519.00 thousand

    Gross margin

    -
    TYRA annual gross profit margin value is unknown

    Operating profit

    -$104.18M
    TYRA annual operating income is -$104.18 million

    Operating margin

    -
    TYRA annual operating profit margin value is unknown

    Net income

    -$86.48M
    TYRA annual net profit is -$86.48 million

    Net margin

    -
    TYRA annual net profit margin value is unknown

    Expenses

    Total expenses

    $104.18M
    TYRA annual total expenses is $104.18 million

    Operating expenses

    $104.18M
    TYRA annual total operating expenses is $104.18 million

    Cost of goods sold

    $519.00K
    TYRA annual cost of goods sold is $519.00 thousand

    Selling, general & administrative expenses

    $24.10M
    TYRA annual SGA is $24.10 million

    Depreciation and amortization

    $519.00K
    TYRA annual depreciation & amortization is $519.00 thousand

    Interest expense

    $0.00
    TYRA annual interest expense is $0.00

    Income tax

    $0.00
    TYRA annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$104.18M
    TYRA annual earnings before interest & taxes is -$104.18 million

    EBITDA

    -$103.66M
    TYRA annual EBITDA is -$103.66 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $365.10M
    TYRA annual total assets is $365.10 million

    Non current assets

    $16.09M
    TYRA annual long term assets is $16.09 million

    Current assets

    $347.46M
    TYRA annual total current assets is $347.46 million

    Cash and cash equivalents

    $91.97M
    TYRA annual cash & cash equivalents is $91.97 million

    Accounts receivable

    -
    TYRA annual accounts receivable value is unknown

    Inventory

    $0.00
    TYRA annual inventory is $0.00

    Liabilities

    Total liabilities

    $21.95M
    TYRA annual total liabilities is $21.95 million

    Long term liabilities

    $5.81M
    TYRA annual total long term liabilities is $5.81 million

    Current liabilities

    $14.59M
    TYRA annual total current liabilities is $14.59 million

    Accounts payable

    $590.00K
    TYRA annual accounts payable is $590.00 thousand

    Debt

    Total debt

    $6.22M
    TYRA annual total debt is $6.22 million

    Total debt 1-year change

    -4.22%
    TYRA annual total debt is down -4.22% year-on-year

    Long term debt

    $5.81M
    TYRA annual long term debt is $5.81 million

    Short term debt

    $412.00K
    TYRA annual short term debt is $412.00 thousand

    Equity & Capital

    Shareholders equity

    $343.15M
    TYRA annual stockholders equity is $343.15 million

    Book value

    $343.15M
    TYRA annual book value is $343.15 million

    Retained earnings

    -$251.31M
    TYRA annual retained earnings is -$251.31 million

    Working capital

    $332.87M
    TYRA annual working capital is $332.87 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$69.77M
    TYRA annual cash flow from operations is -$69.77 million

    Cash from operations 1-year change

    -39.16%
    TYRA annual cash flow from operations is down -39.16% year-on-year

    Cash from investing

    -$98.40M
    TYRA annual cash flow from investing activities is -$98.40 million

    Cash from investing 1-year change

    +31.95%
    TYRA annual cash flow from investing activities is up +31.95% year-on-year

    Cash from financing

    $202.14M
    TYRA annual cash flow from financing activities is $202.14 million

    Cash from financing 1-year change

    +13051.4%
    TYRA annual cash flow from financing activities is up +13051.4% year-on-year

    CAPEX

    CAPEX

    $664.00K
    TYRA annual capital expenditures is $664.00 thousand

    CAPEX 1-year change

    -13.77%
    TYRA annual capital expenditures is down -13.77% year-on-year

    Free Cash Flow

    Free cash flow

    -$70.44M
    TYRA annual free cash flow is -$70.44 million

    Free cash flow 1-year change

    -38.36%
    TYRA annual free cash flow is down -38.36% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    TYRA annual gross profit margin value is unknown

    Operating margin

    -
    TYRA annual operating profit margin value is unknown

    Net margin

    -
    TYRA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -29.27%
    TYRA annual return on assets is -29.27%

    ROE

    -31.60%
    TYRA annual return on equity is -31.60%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TYRA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TYRA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.21
    TYRA price to book ratio is 2.21

    PB ratio Sector rank

    56.14%
    TYRA price to book ratio is higher than 56.14% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    TYRA price to sales ratio value is unknown

    PS ratio Sector rank

    -
    TYRA price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $377.03M
    TYRA enterprise value is $377.03 million

    Enterprise value Sector rank

    62.64%
    TYRA enterprise value is higher than 62.64% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.11
    TYRA EV/EBITDA is -3.11

    EV/EBITDA Sector rank

    29.84%
    TYRA EV/EBITDA is higher than 29.84% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    23.81
    TYRA annual current ratio is 23.81

    Quick ratio

    23.81
    TYRA annual quick ratio is 23.81

    Leverage

    Debt to equity

    0.02
    TYRA annual debt to equity ratio is 0.02

    Interest coverage ratio

    -
    TYRA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    TYRA piotroski f-score value is unknown

    Altman Z-Score

    17.43
    TYRA altman z-score is 17.43

    Analyst ratings

    Recent major analysts updates

    Sep 3, 25 Raymond James
    Strong Buy
    Aug 22, 25 HC Wainwright & Co.
    Buy
    Jul 1, 25 HC Wainwright & Co.
    Buy
    Mar 31, 25 HC Wainwright & Co.
    Buy
    Feb 18, 25 HC Wainwright & Co.
    Buy
    Jan 13, 25 HC Wainwright & Co.
    Buy
    Jan 7, 25 UBS
    Buy
    Nov 11, 24 HC Wainwright & Co.
    Buy
    Oct 29, 24 HC Wainwright & Co.
    Buy
    Oct 28, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with TYRA included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Tyra Biosciences, Inc.?
    • Does Tyra Biosciences, Inc. pay dividends?
    • What sector is Tyra Biosciences, Inc. in?
    • What industry is Tyra Biosciences, Inc. in?
    • What country is Tyra Biosciences, Inc. based in?
    • When did Tyra Biosciences, Inc. go public?
    • Is Tyra Biosciences, Inc. in the S&P 500?
    • Is Tyra Biosciences, Inc. in the NASDAQ 100?
    • Is Tyra Biosciences, Inc. in the Dow Jones?
    • When was Tyra Biosciences, Inc.'s last earnings report?
    • When does Tyra Biosciences, Inc. report earnings?

    What is the ticker symbol for Tyra Biosciences, Inc.?

    The ticker symbol for Tyra Biosciences, Inc. is NASDAQ:TYRA

    Does Tyra Biosciences, Inc. pay dividends?

    No, Tyra Biosciences, Inc. does not pay dividends

    What sector is Tyra Biosciences, Inc. in?

    Tyra Biosciences, Inc. is in the Healthcare sector

    What industry is Tyra Biosciences, Inc. in?

    Tyra Biosciences, Inc. is in the Biotechnology industry

    What country is Tyra Biosciences, Inc. based in?

    Tyra Biosciences, Inc. is headquartered in United States

    When did Tyra Biosciences, Inc. go public?

    Tyra Biosciences, Inc.'s initial public offering (IPO) was on September 15, 2021

    Is Tyra Biosciences, Inc. in the S&P 500?

    No, Tyra Biosciences, Inc. is not included in the S&P 500 index

    Is Tyra Biosciences, Inc. in the NASDAQ 100?

    No, Tyra Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Tyra Biosciences, Inc. in the Dow Jones?

    No, Tyra Biosciences, Inc. is not included in the Dow Jones index

    When was Tyra Biosciences, Inc.'s last earnings report?

    Tyra Biosciences, Inc.'s most recent earnings report was on August 14, 2025

    When does Tyra Biosciences, Inc. report earnings?

    The next expected earnings date for Tyra Biosciences, Inc. is November 6, 2025
    On this page